Innovation Pharmaceuticals Inc (IPIX)

[TheDane]

A Brilicidin inhaler is a game changer but we can’t get there until we’re in human trials for Covid. At least not realistically. Without the Covid connection IPIX couldn’t do much of anything at this time and we’d likely suffer a slow dwindling away. I’m confident in saying, that Leo was able to get BrilAcidin into the RBL for testing against Covid, and the resulting RBL (third party!) confirmation of the potential for BrilAcidin to treat Covid and, perhaps, other viruses, saved the company. I’d love to hear the details of how he did this some day.

Leo’s strategy to develop BrilAcidin as a Platform drug could be the key to vast wealth for him and other shareholders. The only problem is it takes time. Getting this stock to proper valuation based on yesterday’s and other near term news will relieve pressure for the company and “true longs.” I won’t mind waiting a round a few more years with the stock in the upper single digits, say, ranging between $5 and $9.99999999. Oh, on NYSE or Naz, of course. If the next few months shows BrilAcidin helping Covid patients then $9.9999999 will be toast, at least for a while.

Go Leo!